Matching articles for "baxdrostat"
Baxdrostat (Baxfendy) — An Aldosterone Synthase Inhibitor for Hypertension
The FDA has approved baxdrostat ( Baxfendy – AstraZeneca), an oral aldosterone synthase inhibitor, for add-on treatment of hypertension in adults whose blood pressure is not adequately controlled on other…
Med Lett Drugs Ther. 2026 Jul 6; 68(1758):105-6 doi:10.58347/tml.2026.1758a
The FDA has approved baxdrostat ( Baxfendy – AstraZeneca), an oral aldosterone synthase inhibitor, for add-on treatment of hypertension in adults whose blood pressure is not adequately controlled on other drugs. Baxdrostat is the first aldosterone synthase inhibitor to become available in the US.
In Brief: Primary Aldosteronism Screening in Patients with Hypertension
Recently published guidelines recommend screening patients with hypertension for primary aldosteronism. The Endocrine Society recommends screening all patients and the American College of Cardiology/American…
Med Lett Drugs Ther. 2025 Nov 10; 67(1741):184 doi:10.58347/tml.2025.1741e
Recently published guidelines recommend screening patients with hypertension for primary aldosteronism. The Endocrine Society recommends screening all patients and the American College of Cardiology/American Heart Association (ACC/AHA) recommend screening those at increased risk (see Table 1).
